Related Experiment Video

Updated: Jul 19, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Pharmacy fill patterns in young urban children with persistent asthma

Kim Mudd1, Mary Elizabeth Bollinger, Van Doren Hsu

  • 1Division of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. Kmudd2@jhmi.edu

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|October 20, 2006
PubMed

Insights

This study found that children with persistent asthma often had low medication adherence, indicated by poor prescription fill rates for both rescue and controller medications, leading to increased healthcare utilization.

Area of Science:

  • Pediatric Pulmonology
  • Health Services Research
  • Pharmacoeconomics

Background:

  • Medication adherence is a critical determinant of healthcare utilization patterns.
  • Pharmacy records offer a valuable tool for assessing medication fill patterns and adherence.

Purpose of the Study:

  • To evaluate medication fill patterns in children with persistent asthma.
  • To compare these patterns with healthcare utilization data.

Main Methods:

  • Pharmacy records were analyzed for 175 children diagnosed with persistent asthma.
  • Healthcare utilization metrics were collected and compared against medication fill data.

Main Results:

  • A significant proportion of subjects exhibited high healthcare utilization.
  • Low fill rates were observed for both rescue and controller asthma medications.
  • Increased use of rescue medications correlated with higher healthcare utilization and controller medication use.

Conclusions:

  • Pharmacy fill data revealed suboptimal adherence to both rescue and controller asthma medications.
  • Higher rescue medication use was associated with increased healthcare utilization, even when controller medications were prescribed.
Abstract

More Related Videos

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...